BioXcel Therapeutics, Inc. (BTAI)

NASDAQ: BTAI · IEX Real-Time Price · USD

2.630

+0.020 (0.77%)

At close: Apr 26, 2024, 4:00 PM

2.640

+0.010 (0.38%)

After-hours: Apr 26, 2024, 7:34 PM EDT

BioXcel Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017
Market Capitalization	97	86	602	569	1,126	263	60	-
Market Cap Growth	-	-85.65%	5.82%	-49.47%	327.27%	336.30%	-	-
Enterprise Value	133	122	502	337	914	232	18	-1
PE Ratio	-0.48	-0.48	-3.63	-5.32	-13.70	-7.99	-3.13	-
PS Ratio	70.58	62.58	1605.17	-	-	-	-	-
PB Ratio	-1.53	-1.53	7.84	2.57	5.45	9.80	1.55	-
P/FCF Ratio	-0.56	-0.56	-4.44	-6.89	-16.89	-9.42	-4.36	-
P/OCF Ratio	-0.56	-0.56	-4.45	-6.92	-16.97	-9.72	-4.47	-
EV/Sales Ratio	96.53	88.53	1338.80	-	-	-	-	-
EV/EBITDA Ratio	-0.74	-0.74	-3.19	-3.16	-11.15	-7.08	-0.93	0.11
EV/EBIT Ratio	-0.74	-0.74	-3.19	-3.15	-11.13	-7.04	-0.93	0.11
EV/FCF Ratio	-0.79	-0.79	-3.71	-4.08	-13.71	-8.30	-1.29	0.23
Debt / Equity Ratio	-1.79	-1.79	1.22	0.00	0.01	0.04	-	-0.38
Debt / EBITDA Ratio	-0.61	-0.61	-0.60	-0.01	-0.02	-0.03	-	-0.08
Debt / FCF Ratio	-0.65	-0.65	-0.69	-0.01	-0.02	-0.04	-	-0.17
Quick Ratio	2.39	2.39	5.90	13.98	18.00	3.83	9.16	0.38
Current Ratio	2.65	2.65	6.17	14.21	18.33	4.03	9.26	0.38
Asset Turnover	0.01	0.01	0.00	0	0	0	0	0
Interest Coverage	-12.45	-12.45	-19.18	-2672.27	-3042.30	-1647.40	-	-
Return on Equity (ROE)	1872.60%	1872.60%	-118.00%	-46.40%	-59.40%	-111.00%	-41.30%	695.10%
Return on Assets (ROA)	-144.90%	-144.90%	-72.90%	-43.50%	-53.40%	-85.20%	-38.70%	-666.50%
Return on Capital (ROIC)	-385.77%	-385.77%	-93.57%	-48.00%	-39.55%	-120.33%	-51.33%	742.55%
Earnings Yield	-183.83%	-207.35%	-27.54%	-18.80%	-7.30%	-12.51%	-31.91%	-
FCF Yield	-159.16%	-179.52%	-22.51%	-14.52%	-5.92%	-10.62%	-22.93%	-
Buyback Yield / Dilution	-3.98%	-3.98%	-6.23%	-21.63%	-33.11%	-11.79%	-50.45%	-2.16%
Total Shareholder Return	-3.98%	-3.98%	-6.23%	-21.63%	-33.11%	-11.79%	-50.45%	-2.16%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).